Navigation Links
CardioVascularCS.Org, a division of EndoVascular Forum, Inc., Partners with Complex Interventional Cardiovascular Therapy (CICT) to Extend Electronic Medical Care Advancement
Date:6/2/2009

CardioVascularCS.Org and CICT collaborate by reconstructing cardiovascular clinical experiences presented virtually at the annual CICT conference

BOSTON, June 2 /PRNewswire/ -- The EndoVascular Forum, Inc. (EVF), an IC Sciences Company, and its partner Complex Interventional Cardiovascular Therapy (CICT) announced a collaboration using EVF's CardioVascularCS.Org operating division to extend the influence of Electronic Medical Care Advancement for complex clinical skills development in Cardiovascular medicine. The partnership underscores the EndoVascular Forum's commitment to developing a new generation of tools for physicians to learn from peer experiences and to improve clinical treatment decisions and practices. "We are pleased to have the opportunity to collaborate with Complex Interventional Cardiovascular Therapy," said John Heinen, Chief Technology Officer of Informed Clinical Sciences Corporation. "It is the mutual goal of CardioVascularSC.Org and the CICT that this will lead to a stronger partnership in the exchange of clinical experience through case studies and experiential narratives, as well as traffic general observations, clinical pearls, tips, and best practices regarding diagnostic skills, procedural skills, clinical data, and discoveries."

It is now commonly accepted that the Internet is powering a new era of Electronic Medical Care, science, and clinical development in which the massive integration of experiences and observations in and of themselves form a complementary, accelerated path to knowledge generation and dissemination. "The end goal of this partnership is to expand and to extend the essential link that exists between physicians learning from one another at the annual CICT meeting to the CardioVascularCS.Org platform in a way that provides the tools and support on an optimized virtual platform that allows for medical specialists to effectively treat their patients, seek to improve outcomes, and collaborate to advance health care," said Issam D. Moussa, MD and co-director of CICT. The Cardiovascular Forum's online, global clinician network of 11,000 physicians provides an experientially diverse community ideal for collective intelligence engagement around cardiovascular medicine and care.

The CardioVascular Forum's Electronic Medical Care Advancement instruments are part of the class of collective intelligence instruments that apply scientific design principles to effectively engage groups of clinicians or patients in exchanging information, observations, and viewpoints to advance the community's collective intelligence. Techniques employed for high-impact collective intelligence instruments include narrative tools, user-generated tagging, and meta-data collection.

About Complex Interventional Cardiovascular Therapy

The Mission of CICT is to promote high-quality, patient centered, clinical and technical decision-making in the field of Interventional Cardiovascular Medicine. CICT will accomplish its mission by creating a Forum where experts in cardiac and vascular interventions share their experiences with an audience of their peers through interactive complex case presentations. This forum will encourage open and critical discussion of the material presented, as well as relevant "standards of care." The overriding goal of this meeting is to emphasize the role of critical thinking and clinical judgment in transferring knowledge from the evidence based medicine repertoire to the bedside. To learn more about CICT, please visit cict2009.org.

About EndoVascular Forum, Inc.

Founded in 1996, the EndoVascular Forum, Inc. is one of the world's longest standing specialty specific medical forums dedicated to cardiovascular and endovascular specialists. The EVF is an international case study and discussion forum developed and hosted by IC Sciences Corporation (www.ICSciences.com). The EVF NGHI (next generation health Internet) community comes together to share clinical observations, findings, and cases that all serve to accelerate the awareness and adoption of the most innovative and sometimes controversial procedures among physicians in the minimally invasive medical community. To learn more about the EndoVascular Forum, please visit www.Endovascular.org.

About Informed Clinical Sciences Corporation

IC Sciences Corporation is a closely held, private organization pioneering in the medical information sciences and informed clinical technology electronic markets. The company's core business involves designing, developing, delivering, and advancing a series of informatics instrument classes, including care delivery, cognitive profiling, collective intelligence, therapeutic support, and performance evaluation. For more information, please visit www.ICSciences.com.

    Contact:
    IC Sciences Corporation
    publicrelations@icsciences.com
    One Joy Street
    Boston, MA 02108
    1-866-804-6296


'/>"/>
SOURCE IC Sciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Strykers Biotech Division Receives FDA Warning Letter
2. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
3. Hydrox Inc., Cardinal Health Issue Nationwide Recall of Alcohol-Free Mouthwash For Hospitals
4. CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
10. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
11. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/26/2016)... Aliso Viejo, California (PRWEB) , ... June 26, 2016 , ... ... for Final Cut Pro X. , "Film editors can give their videos a whole ... artistically," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):